• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CDKN2B 表达与皮下脂肪组织扩展性:9p21 动脉粥样硬化位点的可能影响。

CDKN2B expression and subcutaneous adipose tissue expandability: possible influence of the 9p21 atherosclerosis locus.

机构信息

Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Sweden.

Department of Genomics of Common Disease, School of Public Health, Imperial College London, UK.

出版信息

Biochem Biophys Res Commun. 2014 Apr 18;446(4):1126-31. doi: 10.1016/j.bbrc.2014.03.075. Epub 2014 Mar 25.

DOI:10.1016/j.bbrc.2014.03.075
PMID:24680834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4003348/
Abstract

Risk alleles within a gene desert at the 9p21 locus constitute the most prevalent genetic determinant of cardiovascular disease. Previous research has demonstrated that 9p21 risk variants influence gene expression in vascular tissues, yet the biological mechanisms by which this would mediate atherosclerosis merits further investigation. To investigate possible influences of this locus on other tissues, we explored expression patterns of 9p21-regulated genes in a panel of multiple human tissues and found that the tumor suppressor CDKN2B was highly expressed in subcutaneous adipose tissue (SAT). CDKN2B expression was regulated by obesity status, and this effect was stronger in carriers of 9p21 risk alleles. Covariation between expression of CDKN2B and genes implemented in adipogenesis was consistent with an inhibitory effect of CDKN2B on SAT proliferation. Moreover, studies of postprandial triacylglycerol clearance indicated that CDKN2B is involved in down-regulation of SAT fatty acid trafficking. CDKN2B expression in SAT correlated with indicators of ectopic fat accumulation, including markers of hepatic steatosis. Among genes regulated by 9p21 risk variants, CDKN2B appears to play a significant role in the regulation of SAT expandability, which is a strong determinant of lipotoxicity and therefore might contribute to the development of atherosclerosis.

摘要

9p21 基因座内的风险等位基因是心血管疾病最常见的遗传决定因素。先前的研究表明,9p21 风险变体影响血管组织中的基因表达,但这种影响介导动脉粥样硬化的生物学机制值得进一步研究。为了研究该基因座对其他组织的可能影响,我们在一组多种人类组织中探索了 9p21 调控基因的表达模式,发现肿瘤抑制因子 CDKN2B 在皮下脂肪组织 (SAT) 中高度表达。CDKN2B 的表达受肥胖状态调节,而携带 9p21 风险等位基因的个体的这种影响更强。CDKN2B 表达与参与脂肪生成的基因之间的共变与 CDKN2B 对 SAT 增殖的抑制作用一致。此外,对餐后三酰甘油清除的研究表明,CDKN2B 参与下调 SAT 脂肪酸转运。SAT 中的 CDKN2B 表达与异位脂肪积累的指标相关,包括肝脂肪变性的标志物。在受 9p21 风险变体调控的基因中,CDKN2B 似乎在调节 SAT 可扩展性方面发挥着重要作用,而 SAT 可扩展性是脂毒性的一个强有力决定因素,因此可能有助于动脉粥样硬化的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bf/4003348/a92ed0f25789/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bf/4003348/e888c6c4acaf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bf/4003348/a92ed0f25789/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bf/4003348/e888c6c4acaf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bf/4003348/a92ed0f25789/gr2.jpg

相似文献

1
CDKN2B expression and subcutaneous adipose tissue expandability: possible influence of the 9p21 atherosclerosis locus.CDKN2B 表达与皮下脂肪组织扩展性:9p21 动脉粥样硬化位点的可能影响。
Biochem Biophys Res Commun. 2014 Apr 18;446(4):1126-31. doi: 10.1016/j.bbrc.2014.03.075. Epub 2014 Mar 25.
2
Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells.血管平滑肌细胞中染色体 9p21 上与冠心病相关变异的功能分析。
Hum Mol Genet. 2012 Sep 15;21(18):4021-9. doi: 10.1093/hmg/dds224. Epub 2012 Jun 15.
3
CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels.CDKN2B调节缺氧新血管的TGFβ信号传导和平滑肌细胞募集
Circ Res. 2016 Jan 22;118(2):230-40. doi: 10.1161/CIRCRESAHA.115.307906. Epub 2015 Nov 23.
4
CDKN2B gene expression is affected by 9p21.3 rs10757278 in CAD patients, six months after the MI.CDKN2B 基因的表达受 CAD 患者 MI 后 6 个月时 9p21.3 rs10757278 的影响。
Clin Biochem. 2019 Nov;73:70-76. doi: 10.1016/j.clinbiochem.2019.08.003. Epub 2019 Aug 3.
5
Genetic variants at 9p21.3 are associated with risk of esophageal squamous cell carcinoma in a Chinese population.9号染色体短臂2区1带3亚区的基因变异与中国人群食管鳞状细胞癌风险相关。
Cancer Sci. 2017 Feb;108(2):250-255. doi: 10.1111/cas.13130.
6
Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus.9号染色体p21.3区域冠心病风险位点的功能分析。
Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1671-7. doi: 10.1161/ATVBAHA.109.189522. Epub 2009 Jul 10.
7
Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.周期蛋白依赖性激酶抑制剂 2B 调节胞吐作用和动脉粥样硬化。
J Clin Invest. 2014 Mar;124(3):1083-97. doi: 10.1172/JCI70391. Epub 2014 Feb 17.
8
ANRIL expression is associated with atherosclerosis risk at chromosome 9p21.ANRIL 表达与 9p21 染色体上的动脉粥样硬化风险相关。
Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):620-7. doi: 10.1161/ATVBAHA.109.196832. Epub 2010 Jan 7.
9
Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.9p21 基因座的遗传变异通过调节 ANRIL 和 CDKN2A/B 促进动脉粥样硬化。
Atherosclerosis. 2012 Feb;220(2):449-55. doi: 10.1016/j.atherosclerosis.2011.11.017. Epub 2011 Nov 19.
10
Interferon-γ activates expression of p15 and p16 regardless of 9p21.3 coronary artery disease risk genotype.干扰素-γ 可激活 p15 和 p16 的表达,与 9p21.3 冠状动脉疾病风险基因型无关。
J Am Coll Cardiol. 2013 Jan 15;61(2):143-7. doi: 10.1016/j.jacc.2012.08.1020. Epub 2012 Nov 28.

引用本文的文献

1
An explorative study on the interaction of cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1/ANRIL) gene polymorphism with obesity on periodontitis among Norwegian adults.挪威成年人中细胞周期蛋白依赖性激酶抑制剂2B反义RNA1(CDKN2B-AS1/ANRIL)基因多态性与肥胖对牙周炎相互作用的探索性研究。
Acta Odontol Scand. 2025 Aug 14;84:426-438. doi: 10.2340/aos.v84.44368.
2
Unraveling the understudied influence of a lead variant in the 9p21 locus on the atherogenic index among type 2 diabetes patients with coronary artery disease.揭示9p21基因座中一个研究较少的主要变异对2型糖尿病合并冠状动脉疾病患者动脉粥样硬化指数的影响。
J Diabetes Metab Disord. 2024 May 31;23(2):1879-1885. doi: 10.1007/s40200-024-01437-z. eCollection 2024 Dec.
3

本文引用的文献

1
Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.周期蛋白依赖性激酶抑制剂 2B 调节胞吐作用和动脉粥样硬化。
J Clin Invest. 2014 Mar;124(3):1083-97. doi: 10.1172/JCI70391. Epub 2014 Feb 17.
2
CDKN2B expression in adipose tissue of familial combined hyperlipidemia patients.家族性复合型高脂血症患者脂肪组织中 CDKN2B 的表达。
J Lipid Res. 2013 Dec;54(12):3491-505. doi: 10.1194/jlr.M041814. Epub 2013 Oct 8.
3
Macrophage gene expression in adipose tissue is associated with insulin sensitivity and serum lipid levels independent of obesity.
Deletion of the Murine Ortholog of the Human 9p21.3 Locus Leads to Insulin Resistance and Obesity in Hypercholesterolemic Mice.敲除人 9p21.3 座标上的同源基因导致高胆固醇血症小鼠胰岛素抵抗和肥胖
Cells. 2024 Jun 5;13(11):983. doi: 10.3390/cells13110983.
4
An Atlas of Promoter Chromatin Modifications and HiChIP Regulatory Interactions in Human Subcutaneous Adipose-Derived Stem Cells.人皮下脂肪干细胞启动子染色质修饰和 HiChIP 调控相互作用图谱
Int J Mol Sci. 2023 Dec 28;25(1):437. doi: 10.3390/ijms25010437.
5
Knocking Down in 3D hiPSC-Derived Brown Adipose Progenitors Potentiates Differentiation, Oxidative Metabolism and Browning Process.在 3D 高分辨率 iPSC 衍生棕色前体细胞中敲除增强分化、氧化代谢和棕色化过程。
Cells. 2023 Mar 10;12(6):870. doi: 10.3390/cells12060870.
6
Effect of 9p21.3 (lncRNA and CDKN2A/2B) variant on lipid profile.9p21.3(长链非编码RNA和CDKN2A/2B)变异对血脂谱的影响。
Front Cardiovasc Med. 2022 Sep 7;9:946289. doi: 10.3389/fcvm.2022.946289. eCollection 2022.
7
Altered regulation of mesenchymal cell senescence in adipose tissue promotes pathological changes associated with diabetic wound healing.脂肪组织间充质细胞衰老的调节改变促进了与糖尿病伤口愈合相关的病理变化。
Commun Biol. 2022 Apr 5;5(1):310. doi: 10.1038/s42003-022-03266-3.
8
Analysis of the interaction effect of 48 SNPs and obesity on type 2 diabetes in Chinese Hans.分析 48 个单核苷酸多态性与肥胖对中国汉族人 2 型糖尿病的交互作用。
BMJ Open Diabetes Res Care. 2020 Nov;8(2). doi: 10.1136/bmjdrc-2020-001638.
9
Elevated methylation of cyclin dependent kinase inhibitor 2B contributes to the risk of coronary heart disease in women.细胞周期蛋白依赖性激酶抑制剂2B的甲基化水平升高会增加女性患冠心病的风险。
Exp Ther Med. 2019 Jan;17(1):205-213. doi: 10.3892/etm.2018.6920. Epub 2018 Nov 2.
10
Dietary patterns interact with chromosome 9p21 rs1333048 polymorphism on the risk of obesity and cardiovascular risk factors in apparently healthy Tehrani adults.饮食模式与染色体 9p21 rs1333048 多态性相互作用,影响伊朗成年人明显健康人群的肥胖和心血管风险因素的发生风险。
Eur J Nutr. 2020 Feb;59(1):35-43. doi: 10.1007/s00394-018-1872-1. Epub 2019 Jan 2.
脂肪组织中巨噬细胞的基因表达与胰岛素敏感性和血清脂质水平有关,而与肥胖无关。
Obesity (Silver Spring). 2013 Dec;21(12):E571-6. doi: 10.1002/oby.20443. Epub 2013 Jun 13.
4
ANRIL: molecular mechanisms and implications in human health.ANRIL:分子机制及其对人类健康的影响
Int J Mol Sci. 2013 Jan 10;14(1):1278-92. doi: 10.3390/ijms14011278.
5
Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells.血管平滑肌细胞中染色体 9p21 上与冠心病相关变异的功能分析。
Hum Mol Genet. 2012 Sep 15;21(18):4021-9. doi: 10.1093/hmg/dds224. Epub 2012 Jun 15.
6
Serum alanine aminotransferase concentration as a predictive factor for the development or regression of fatty liver.血清丙氨酸氨基转移酶浓度作为预测脂肪肝发生或消退的指标。
J Clin Biochem Nutr. 2011 Nov;49(3):200-6. doi: 10.3164/jcbn.11-27. Epub 2011 Aug 24.
7
Genomewide association studies in cardiovascular disease--an update 2011.心血管疾病全基因组关联研究——2011 年最新进展
Clin Chem. 2012 Jan;58(1):92-103. doi: 10.1373/clinchem.2011.170431. Epub 2011 Nov 28.
8
TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.TAZ 拮抗 WWP1 介导的 KLF5 降解,促进乳腺细胞增殖和肿瘤发生。
Carcinogenesis. 2012 Jan;33(1):59-67. doi: 10.1093/carcin/bgr242. Epub 2011 Oct 31.
9
The effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study.9p21 染色体变异对心血管疾病的影响可能受到饮食摄入的影响:病例对照和前瞻性研究的证据。
PLoS Med. 2011 Oct;8(10):e1001106. doi: 10.1371/journal.pmed.1001106. Epub 2011 Oct 11.
10
Genetic mechanisms mediating atherosclerosis susceptibility at the chromosome 9p21 locus.介导 9p21 染色体部位动脉粥样硬化易感性的遗传机制。
Curr Atheroscler Rep. 2011 Jun;13(3):193-201. doi: 10.1007/s11883-011-0178-z.